BofA/Merrill Lynch Upgrades Bio-Reference Laboratories (BRLI) to Buy
Tweet
Share
E-mailGet Alerts BRLI Hot Sheet
Price: $4.70 --0%
Rating Summary:
0 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 13 | New: 16
Rating Summary:
0 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 13 | New: 16
Join SI Premium – FREE
BofA/Merrill Lynch upgraded Bio-Reference Laboratories (NASDAQ: BRLI) from Neutral to Buy.
For an analyst ratings summary and ratings history on Bio-Reference Laboratories click here. For more ratings news on Bio-Reference Laboratories click here.
Shares of Bio-Reference Laboratories closed at $21.71 yesterday.
For an analyst ratings summary and ratings history on Bio-Reference Laboratories click here. For more ratings news on Bio-Reference Laboratories click here.
Shares of Bio-Reference Laboratories closed at $21.71 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Upgrades Oxford Biomedica (OXB:LN) (OXBDF) to Buy
- Northern Trust (NTRS) PT Raised to $101 at BofA Securities
- Interactive Brokers Group (IBKR) PT Raised to $152 at BofA Securities
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
